NCT04247802

Brief Summary

Backwards walking has been shown to improve balance and walking in patients who have knee Osteoarthritis. It is not known if these benefits may also be seen after surgery in patients who have had a hip or knee replacement because of Osteoarthritis. This study will look to see if it is possible to conduct a bigger study into how effective backwards walking may be after joint replacement. Patients who come to the Nuffield Orthopaedic Centre in Oxford for a hip or knee replacement will be invited. They will be placed into one of two groups at random: a group where they have a course of physiotherapy plus a backwards walking programme or a group where they have a course of physiotherapy. The physiotherapy will last for 12 weeks and those who take part will have two study assessments. The first will be before any treatment and patients will complete five measures and also be issued with a simple tick box diary to complete over the 12 weeks. The second assessment will be after the treatment and will involve the same five measures and the diaries will be collected in. Participants at this assessment will also be asked if they would like to take part in an interview for the study. This is to see what the patients thought of the study. During the study the researcher will record things such as how many patients say 'yes' to the study and how many participants drop out of the treatment, to understand if a bigger study could take place.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

August 5, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
3 years until next milestone

Results Posted

Study results publicly available

January 10, 2025

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

January 28, 2020

Results QC Date

January 15, 2024

Last Update Submit

November 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Berg Balance Scale

    The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function. All the item scores are combined to make a total from a minimum of 0 to a maximum of 56. Scores between 41-56 indicate a low risk of falls, 21-40 a medium risk and, below 20 a high risk of falls.

    12 weeks

Secondary Outcomes (4)

  • Four Square Step Test

    12 weeks

  • The Two Minute Walk Test (2MWT)

    12 weeks

  • 30 Second Sit to Stand Test

    12 weeks

  • Activities-Specific Balance Confidence Scale

    12 weeks

Study Arms (2)

Backwards Walking (BW) programme

EXPERIMENTAL

This group will undertake a routine course of one to one out-patient physiotherapy which will include a BW programme. The BW programme will be prescribed by a physiotherapist and the participant will carry it out, along with other prescribed exercises, in their own home. Each participant will initially be prescribed a 5 minute BW programme to be completed once a day. The length of the BW programme and intensity will be progressed or regressed as deemed appropriate by the treating clinician with the aim for patients to achieve at least 10 minutes of BW every day of the week.

Other: Backwards Walking (BW) programme

Usual Care

ACTIVE COMPARATOR

This group will undertake a routine course of one to one out-patient physiotherapy over 12 weeks. To allow comparison between the two groups the control group will also have up to four review appointments where their home exercise programme can be progressed or regressed. The physiotherapy treatments will be not be restricted (apart from no BW programme) to allow for a pragmatic approach based on the treating clinician's clinical judgement, however their content will be recorded on treatment logs.

Other: Usual Care

Interventions

A 12 week Backwards walking programme prescribed by a registered physiotherapist and completed as part of a home exercise programme.

Backwards Walking (BW) programme

A 12 week physiotherapy exercise programme EXCLUDING backwards walking

Usual Care

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Men and women aged 65 or older.
  • Participant is willing and able to give informed consent for participation in the study.
  • Participants who have received a primary unilateral hip or knee arthroplasty due to osteoarthritis.

You may not qualify if:

  • Post-operative weight bearing restrictions.
  • Post-operative complications such as infection, a deep vein thrombosis or pulmonary embolism, or failure of the wound to heal.
  • Inability to undertake a backwards walking programme due to conditions such as severe cardiovascular or pulmonary disease (New York Heart Association III-IV).
  • Severe dementia or communication difficulties that would prevent completion of study assessments.
  • Any neurological condition.
  • Further planned treatment on the same or contralateral hip or knee within the next 6 months.
  • Registered as visually impaired.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Horton General Hospital

Banbury, Oxfordshire, OX16 9AL, United Kingdom

Location

Nuffield Orthopaedic Centre

Oxford, Oxfordshire, OX3 7HE, United Kingdom

Location

MeSH Terms

Conditions

Osteoarthritis, HipOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Results Point of Contact

Title
Mrs Martha Batting
Organization
Oxford University Hospitals NHS Foundation Trust

Study Officials

  • Martha Batting

    Oxford University Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2020

First Posted

January 30, 2020

Study Start

August 5, 2020

Primary Completion

October 15, 2021

Study Completion

December 31, 2021

Last Updated

January 10, 2025

Results First Posted

January 10, 2025

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations